規制動向

FDA、EMA、TGA および世界の規制動向

#Methyltestosterone ×

2026年9月12日•1分で読めます

FDA Approves Labeling for ORETON Buccal Tablet (Methyltestosterone 10 mg) – ANDA080281

The FDA approved labeling for SCHERING's ORETON buccal tablet containing 10 mg methyltestosterone (application ANDA080281). The product is listed as discontinued.

2026年8月30日•1分で読めます

FDA Approves Lilly Methyltestosterone Tablet ANDA080256 (Discontinued)

FDA approved Lilly's ANDA080256 for methyltestosterone tablets (10 mg and 25 mg) buccal/sublingual on Dec 22 1971; both products are now discontinued.